OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nectin‐4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin
Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Journal of Cutaneous Pathology (2024) Vol. 51, Iss. 5, pp. 360-367
Closed Access | Times Cited: 4
Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Journal of Cutaneous Pathology (2024) Vol. 51, Iss. 5, pp. 360-367
Closed Access | Times Cited: 4
Showing 4 citing articles:
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence
Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Life Sciences (2024) Vol. 352, pp. 122910-122910
Closed Access | Times Cited: 7
Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Life Sciences (2024) Vol. 352, pp. 122910-122910
Closed Access | Times Cited: 7
A Peptide Derived from Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells from Ovarian Cancer Patients’ Ascites
Kristin L.M. Boylan, Christoph Walz, Alexandra Schefter, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 901-901
Open Access
Kristin L.M. Boylan, Christoph Walz, Alexandra Schefter, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 901-901
Open Access
Characterizing ADRs of Enfortumab vedotin and Erdafitinib in bladder cancer treatment: a descriptive analysis from WHO-VigiAccess
Yuanbin Huang, Meiqi Xu, Xiuli Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Yuanbin Huang, Meiqi Xu, Xiuli Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Digital Papillary Adenocarcinoma Is HPV-42-Associated and BRAFV600E Negative: Perspectives for Diagnostic Practice
Tassilo Dege, Arno Rütten, Matthias Goebeler, et al.
Dermatopathology (2024) Vol. 11, Iss. 4, pp. 348-353
Open Access
Tassilo Dege, Arno Rütten, Matthias Goebeler, et al.
Dermatopathology (2024) Vol. 11, Iss. 4, pp. 348-353
Open Access
